Immunity evaluation in children with recurrent respiratory tract infections (RRTIs)

M. Canciani, V. Gregorutti, M. Don, P. Melli, A. Tenore (Udine, Italy)

Source: Annual Congress 2001 - Immune deficiencies and the lung in childhood
Session: Immune deficiencies and the lung in childhood
Session type: Oral Presentation
Number: 3433
Disease area: Paediatric lung diseases

Congress or journal article abstract

Abstract

RRTIs are the most common causes of physician visits and hospitalisation in children, and are responsible for significant morbidity, as well as mortality. Although antibiotics and other medications generally cause remission of the immediate infection, they do not always prevent recurrences.
The aim of this study was to evaluate the immunological status of patients with RRTIs (more than six upper respiratory tract infections or more than three lower respiratory tract infections per year), during a period of clinical remission and off all medications for at least 2 weeks.
The following investigations were carried out in a cohort of patients (pts) aged 8 mo-14 yrs, 66% males: IgG, IgA, IgM serum concentration (80 pts), IgG subclasses (89 pts), lymphocyte subpopulations (CD4, CD8, CD16, CD19, 92 pts), phagocytosis and radical oxygen intermediates production(90 pts). 12 patients (16%) had a serum Ig deficiency: 7 IgM, 5 IgA (3 with total deficiency), 2 IgG (2 pts with combined deficiency). 12 pts (14%) had a total IgG2 deficiency, one a partial deficiency; 4 of these patients (5%) had a phagocytosis or a radical oxygen intermediate production defect. A lymphocyte subpopulations deficiency was detected in 13 pts (14%): 7 CD8, 6 CD16.
In conclusion, a discrete percentage of children with RRTIs, even if in clinical remission, presented a serum humoral and cell-mediate immunity deficit. These results are important in making clinical decisions and in debating the use of immunotherapy, since any diagnostic delay, also of less severe defects, may expose the patients to chronic organ deterioration, such as chronic lung disease.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Canciani, V. Gregorutti, M. Don, P. Melli, A. Tenore (Udine, Italy). Immunity evaluation in children with recurrent respiratory tract infections (RRTIs). Eur Respir J 2001; 16: Suppl. 31, 3433

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunomodulators in preventing recurrent respiratory tract infections (RRTI): a meta-analysis*
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002

Incidence and severity of viral respiratory tract infections in immunocompromised children
Source: Annual Congress 2009 - Paediatric respiratory epidemiology: respiratory infections and rare diseases
Year: 2009

Prevalence of respiratory pathogens in children hospitalized with lower respiratory tract infection
Source: Eur Respir J 2007; 30: Suppl. 51, 398s
Year: 2007

Antibody deficiency in adults with recurrent respiratory tract infections
Source: Eur Respir J 2001; 18: Suppl. 33, 106s
Year: 2001

Respiratory sound analysis in preschool children with recurrent respiratory tract infections
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Asthma and acute infections of upper respiratory tract in children
Source: Eur Respir J 2006; 28: Suppl. 50, 253s
Year: 2006

Lower respiratory tract infections: challenges in children and adults
Source: Virtual Congress 2020 – Respiratory diseases in children and adults
Year: 2020


Congenital infections of the respiratory tract
Source: Eur Respir Monogr 2021; 92: 245-258
Year: 2021


Viral agents in children with lower respiratory tract infection
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006

Immunological parameters in Down syndrome children with and without recurrent lower respiratory tract infections
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021


Treatment of community-acquired lower respiratory tract infections in adults
Source: Eur Respir J 2002; 20: 40S-53S
Year: 2002



Respiratory diseases and symptoms in children hospitalized for lower respiratory tract infections during infancy: one year follow-up
Source: Eur Respir J 2002; 20: Suppl. 38, 192s
Year: 2002

Nasal microbiota and symptom persistence in acute respiratory tract infections in infants
Source: ERJ Open Res, 4 (4) 00066-2018; 10.1183/23120541.00066-2018
Year: 2018



Aetiology of lower respiratory tract infection (LRTI) in primary care
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004


Effects of respiratory viral infections on the lower respiratory tract of children, especially asthmatic children
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011

Parent-reported recurrent wheeze after RSV lower respiratory tract infection versus non-RSV lower respiratory tract infection
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013


The management of severe sepsis in respiratory tract infections
Source: Annual Congress 2013 –ME14 The management of severe sepsis in respiratory tract infections
Year: 2013



Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Role of α- and β-defensins in lower respiratory tract infections
Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections
Year: 2007


Association of asthma exacerbations and upper respiratory tract infections (URTIs)
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009